Clinical Trial Update: First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19. [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study evaluating safety, tolerability, and pharmacokinetics of PF-07304814 in hospitalized adults with viral disease (COVID-19).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Disease

Drugs mentioned

• PF-07304814 (PF-07304814)

Snippet

Sponsor: Pfizer | Conditions: Viral Disease | Phase 1 | Status: COMPLETED | Results posted: 2023-05-03